Grant: Project Grant
University of Toronto
$688,501.00
Improving bedside screening to detect unsafe swallowing and reduce unnecessary testing
FY 2025-26
Summary
Swallowing problems are common in hospitalized patients, especially after stroke and in older adults. When swallowing fails, food or liquid can enter the lungs. This is called aspiration and can lead to pneumonia, longer hospital stays, restricted diets, and even death. Many patients silently aspirate without coughing or visible warning signs, making detection difficult.
Hospitals use bedside screening tests to identify patients at risk. These tests rely on outward symptoms rather than directly measuring swallowing function. To avoid missing dangerous cases, they are designed to be highly sensitive. As a result, many patients who are actually swallowing safely are referred for unnecessary X-ray tests and placed on restrictive diets, leading to avoidable procedures, higher healthcare costs, and added burden on patients and clinicians.
We have developed a handheld device called the Aspirometer to improve swallowing screening. A small sensor placed on the neck records vibrations and sounds during swallowing, and machine learning analysis identifies patterns linked to unsafe swallowing. This approach measures swallowing physiology directly rather than relying only on visible signs.
In preliminary studies, the Aspirometer maintained high sensitivity for detecting aspiration while significantly reducing false positives compared to current bedside screening. We will now prospectively validate the device in real hospital conditions to determine whether these results hold and whether improved screening performance leads to fewer unnecessary tests, fewer diet restrictions, and better use of clinical resources.
If successful, this technology could provide a safe, low-cost way to detect aspiration at the bedside while reducing unnecessary X-ray referrals. It has the potential to lower pneumonia risk, decrease avoidable procedures, reduce healthcare costs, and help patients eat and drink more safely by supporting more informed clinical decision-making.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
565647
Name
Sejdic Ervin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Improving bedside screening to detect unsafe swallowing and reduce unnecessary testing
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$688,501
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Artificial Intelligence; Aspiration; Biomedical Sensing; Cervical Auscultation; Digital Health; Dysphagia; Machine Learning; Noninvasive Monitoring; Patient Safety; Swallowing Screening
Abstract
Swallowing problems are common in hospitalized patients, especially after stroke and in older adults. When swallowing fails, food or liquid can enter the lungs. This is called aspiration and can lead to pneumonia, longer hospital stays, restricted diets, and even death. Many patients silently aspirate without coughing or visible warning signs, making detection difficult.
Hospitals use bedside screening tests to identify patients at risk. These tests rely on outward symptoms rather than directly measuring swallowing function. To avoid missing dangerous cases, they are designed to be highly sensitive. As a result, many patients who are actually swallowing safely are referred for unnecessary X-ray tests and placed on restrictive diets, leading to avoidable procedures, higher healthcare costs, and added burden on patients and clinicians.
We have developed a handheld device called the Aspirometer to improve swallowing screening. A small sensor placed on the neck records vibrations and sounds during swallowing, and machine learning analysis identifies patterns linked to unsafe swallowing. This approach measures swallowing physiology directly rather than relying only on visible signs.
In preliminary studies, the Aspirometer maintained high sensitivity for detecting aspiration while significantly reducing false positives compared to current bedside screening. We will now prospectively validate the device in real hospital conditions to determine whether these results hold and whether improved screening performance leads to fewer unnecessary tests, fewer diet restrictions, and better use of clinical resources.
If successful, this technology could provide a safe, low-cost way to detect aspiration at the bedside while reducing unnecessary X-ray referrals. It has the potential to lower pneumonia risk, decrease avoidable procedures, reduce healthcare costs, and help patients eat and drink more safely by supporting more informed clinical decision-making.
Competitiondate
202603
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Sejdic, Ervin
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $688,501~ $0~